FIBROGEN INC — Director's Dealing 2016

Mar 17, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-03-16

Reporting Person: Tamura Toshinari (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-03-16	Common Stock	M	24000	$2.35	Acquired	24000	Direct
2016-03-16	Common Stock	M	12000	$2.90	Acquired	36000	Direct
2016-03-16	Common Stock	M	12000	$2.90	Acquired	48000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-03-16	Stock Option (Right to Buy)	$2.35	M	24000	Disposed	2018-09-10	Common Stock (24000)	Direct
2016-03-16	Stock Option (Right to Buy)	$2.90	M	12000	Disposed	2020-06-09	Common Stock (12000)	Direct
2016-03-16	Stock Option (Right to Buy)	$2.90	M	12000	Disposed	2020-06-24	Common Stock (12000)	Direct

Footnotes

F1: Fully vested.